{"id":2183,"date":"2024-05-24T10:20:00","date_gmt":"2024-05-24T08:20:00","guid":{"rendered":"http:\/\/jcet.eu\/new_en\/?p=2183"},"modified":"2024-07-19T13:34:25","modified_gmt":"2024-07-19T11:34:25","slug":"polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium","status":"publish","type":"post","link":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/","title":{"rendered":"POLONEZ BIS-3 &#8211; effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium"},"content":{"rendered":"\n<p><strong>We would like to officially welcome a new member of the JCET team, Aneta Radziwon-Balicka, Ph.D., who will be carrying out a project entitled: <em>&#8220;Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier integrity<\/em>&#8220;, under funding from the POLONEZ BIS-3 programme.<\/strong><\/p>\n\n\n\n<p>POLONEZ BIS is co-funded by the European Commission and the Polish National Science Centre under the Marie Sk\u0142odowska-Curie COFUND grant. In three calls, the programme recruited over 120 experienced researchers from all over the world. They will move to Poland for 24 months to conduct their basic research in public or private institutions of their choice.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png\"><img loading=\"lazy\" decoding=\"async\" width=\"810\" height=\"450\" src=\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png\" alt=\"\" class=\"wp-image-2184\" srcset=\"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png 810w, https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2-300x167.png 300w, https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2-768x427.png 768w\" sizes=\"auto, (max-width: 810px) 100vw, 810px\" \/><\/a><\/figure>\n\n\n\n<!--more-->\n\n\n\n<p>A better understanding of the pathogenesis of cardiovascular complications in patients treated with small molecule inhibitors is urgently needed to improve safety of cancer therapy. In this project we aim to characterize a possible effect of platelets on endothelial cells, to study effects of small molecule inhibitors on functionality of endothelium, and finally, to perform proof of principle, clinical study investigating whether platelets from chronic myeloid leukemia patients untreated or treated with small molecule inhibitors may have different effect on platelets compared to the healthy individuals. We anticipate that this research proposal will bring a novel knowledge regarding platelets and their functional effect on endothelial barrier integrity. In addition, the clinical study will test whether chronic myeloid leukemia patients untreated and treated with small molecule inhibitors may have different effect on platelets and on endothelial barrier integrity.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We would like to officially welcome a new member of the JCET team, Aneta Radziwon-Balicka, Ph.D., who will be carrying out a project entitled: &#8220;Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2183","post","type-post","status-publish","format-standard","hentry","category-varia"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>POLONEZ BIS-3 - effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium &#187; JCET<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"POLONEZ BIS-3 - effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium &#187; JCET\" \/>\n<meta property=\"og:description\" content=\"We would like to officially welcome a new member of the JCET team, Aneta Radziwon-Balicka, Ph.D., who will be carrying out a project entitled: &#8220;Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/\" \/>\n<meta property=\"og:site_name\" content=\"JCET\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/jcet.eu\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-24T08:20:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-19T11:34:25+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png\" \/>\n<meta name=\"author\" content=\"Agnieszka Gudek\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Agnieszka Gudek\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/\"},\"author\":{\"name\":\"Agnieszka Gudek\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#\/schema\/person\/aa0014c9ab5728df0c0977a4c5985ed9\"},\"headline\":\"POLONEZ BIS-3 &#8211; effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium\",\"datePublished\":\"2024-05-24T08:20:00+00:00\",\"dateModified\":\"2024-07-19T11:34:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/\"},\"wordCount\":254,\"publisher\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/#organization\"},\"image\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png\",\"articleSection\":[\"Varia\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/\",\"url\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/\",\"name\":\"POLONEZ BIS-3 - effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium &#187; JCET\",\"isPartOf\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png\",\"datePublished\":\"2024-05-24T08:20:00+00:00\",\"dateModified\":\"2024-07-19T11:34:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#primaryimage\",\"url\":\"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png\",\"contentUrl\":\"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png\",\"width\":810,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jcet.eu\/new_en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"POLONEZ BIS-3 &#8211; effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#website\",\"url\":\"https:\/\/jcet.eu\/new_en\/\",\"name\":\"JCET\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jcet.eu\/new_en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#organization\",\"name\":\"Jagiellonian Centre for Experimental Therapeutics (JCET)\",\"url\":\"https:\/\/jcet.eu\/new_en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2022\/06\/JCET-logo.png\",\"contentUrl\":\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2022\/06\/JCET-logo.png\",\"width\":715,\"height\":401,\"caption\":\"Jagiellonian Centre for Experimental Therapeutics (JCET)\"},\"image\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/jcet.eu\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#\/schema\/person\/aa0014c9ab5728df0c0977a4c5985ed9\",\"name\":\"Agnieszka Gudek\",\"sameAs\":[\"http:\/\/admin\"],\"url\":\"https:\/\/jcet.eu\/new_en\/author\/agag\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"POLONEZ BIS-3 - effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium &#187; JCET","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/","og_locale":"en_GB","og_type":"article","og_title":"POLONEZ BIS-3 - effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium &#187; JCET","og_description":"We would like to officially welcome a new member of the JCET team, Aneta Radziwon-Balicka, Ph.D., who will be carrying out a project entitled: &#8220;Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier","og_url":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/","og_site_name":"JCET","article_publisher":"https:\/\/www.facebook.com\/jcet.eu\/","article_published_time":"2024-05-24T08:20:00+00:00","article_modified_time":"2024-07-19T11:34:25+00:00","og_image":[{"url":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png","type":"","width":"","height":""}],"author":"Agnieszka Gudek","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Agnieszka Gudek","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#article","isPartOf":{"@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/"},"author":{"name":"Agnieszka Gudek","@id":"https:\/\/jcet.eu\/new_en\/#\/schema\/person\/aa0014c9ab5728df0c0977a4c5985ed9"},"headline":"POLONEZ BIS-3 &#8211; effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium","datePublished":"2024-05-24T08:20:00+00:00","dateModified":"2024-07-19T11:34:25+00:00","mainEntityOfPage":{"@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/"},"wordCount":254,"publisher":{"@id":"https:\/\/jcet.eu\/new_en\/#organization"},"image":{"@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#primaryimage"},"thumbnailUrl":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png","articleSection":["Varia"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/","url":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/","name":"POLONEZ BIS-3 - effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium &#187; JCET","isPartOf":{"@id":"https:\/\/jcet.eu\/new_en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#primaryimage"},"image":{"@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#primaryimage"},"thumbnailUrl":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png","datePublished":"2024-05-24T08:20:00+00:00","dateModified":"2024-07-19T11:34:25+00:00","breadcrumb":{"@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#primaryimage","url":"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png","contentUrl":"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2024\/05\/Untitled-design-2.png","width":810,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/jcet.eu\/new_en\/2024\/05\/24\/polonez-bis-3-effects-of-tyrosine-kinase-inhibitors-on-endothelium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jcet.eu\/new_en\/"},{"@type":"ListItem","position":2,"name":"POLONEZ BIS-3 &#8211; effects of tyrosine kinase inhibitors on platelets subpopulations and endothelium"}]},{"@type":"WebSite","@id":"https:\/\/jcet.eu\/new_en\/#website","url":"https:\/\/jcet.eu\/new_en\/","name":"JCET","description":"","publisher":{"@id":"https:\/\/jcet.eu\/new_en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jcet.eu\/new_en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/jcet.eu\/new_en\/#organization","name":"Jagiellonian Centre for Experimental Therapeutics (JCET)","url":"https:\/\/jcet.eu\/new_en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/jcet.eu\/new_en\/#\/schema\/logo\/image\/","url":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2022\/06\/JCET-logo.png","contentUrl":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2022\/06\/JCET-logo.png","width":715,"height":401,"caption":"Jagiellonian Centre for Experimental Therapeutics (JCET)"},"image":{"@id":"https:\/\/jcet.eu\/new_en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/jcet.eu\/"]},{"@type":"Person","@id":"https:\/\/jcet.eu\/new_en\/#\/schema\/person\/aa0014c9ab5728df0c0977a4c5985ed9","name":"Agnieszka Gudek","sameAs":["http:\/\/admin"],"url":"https:\/\/jcet.eu\/new_en\/author\/agag\/"}]}},"_links":{"self":[{"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/posts\/2183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/comments?post=2183"}],"version-history":[{"count":4,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/posts\/2183\/revisions"}],"predecessor-version":[{"id":2319,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/posts\/2183\/revisions\/2319"}],"wp:attachment":[{"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/media?parent=2183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/categories?post=2183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/tags?post=2183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}